Background/Aims: Our previous study suggested the anti-tumor activity of sepia ink oligopeptide (SIO). Here we sought to investigate the underlying molecular mechanism. Methods: Cell proliferation was evaluated by cell counting kit-8 (CCK-8) assay. Cell apoptosis was determined by Annexin V/Propidium Iodide (PI) staining. The mitochondria pathway was characterized by quantification of Bcl-2, Bax, Caspase-9 and Cyto-C. The death receptor pathway was analyzed by determinement of Fas, Caspase-8 and NIK. The endoplasmic reticulum (ER)-dependent pathway was determined by measurement the expression of CHOP, Caspase-12, GRP78 and Calpain. The associated gene expression was quantified by RT-PCR and protein level was determined by immunoblotting. Results: We demonstrated treatment with structurally modified SIO (CSIO, 5 μM) significantly inhibited cell proliferation and induced apoptosis in lung cancer cell line A549. The mitochondrial pathway, death receptor pathway and ER stress induced apoptosis were stimulated upon CSIO treatment. The administration with respective inhibitors including midiv-1 (50 μM for 2 h), PDTC (20 μM PDTC for 30 min) and ALLN (20 mM ALLN for 5 h) readily reversed the apoptosis inducing effect of CSIO. Conclusion: Our data demonstrates that CSIO is capable of induction apoptosis in lung cancer cell line, which is mediated by all three classical apoptotic pathways. Our results warrant further in vivo investigations of the anti-tumor potential of CSIO.
Sepia Ink Oligopeptide Induces Apoptosis of Lung Cancer Cells via Mitochondrial Pathway
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Introduction
Lung cancer is the most common cause of cancer-related death in men and the second most common malignance in women, only after breast cancer [1] . In 2012, 1.8 million new cases of lung cancer were diagnosed and 1.6 million deaths were claimed worldwide. Approximately 4~17 % of 5-year survival rate was estimated, which heavily dependents on early diagnosis and intervention [2] . Histologically, lung cancer could be divided into two subtypes: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), and NSCLC represented the major proportion of lung cancer cases [3] . The epidemiology investigation has demonstrated that around 85% new cases of lung cancer are associated with longterm tobacco smoking [4] . Other risk factors include epigenetic and genetic mutations, occupational exposure to radon gas, asbestos and environmental pollutions [5] . Lung cancer may be detected with regular chest radiographs and computed tomography (CT) scans and diagnosed by biopsy with bronchoscopy. The clinical management option with respect to lung cancer greatly depends on the pathological type, stage and overall health condition. Despite that tremendous progression has been archived in understanding the molecular events during tumorigenesis, progression, metastasis and drug resistance of lung cancer, surgery, chemotherapy and radiotherapy are still the mainstay for clinical treatment [6] . Target therapy has been clinically accepted for patients with well-defined genetic mutations, however, the invoked resistance in short period greatly limited its therapeutic values [7] . Most recently, immunotherapy, based on immune checkpoint blockade, has archived enormous success in both hematologic and solid malignancies, but its intrinsically associated auto-immunity disorder imposed therapeutic constraint [8] . Therefore, novel and efficient reagent is still in urgent need for this disease.
Sepia ink is a natural product and has been used in traditional Chinese medicine (TCM), which has been historically used for hemostasis. Accumulating evidences have suggested other therapeutic values of sepia ink in anti-radiation, anti-oxidation, immunomodulation and procoagulation [9] . Most importantly, a previous and elegant study indicated the antitumor activity of sepia ink in BALB/c mice with Meth-A fibrosarcoma, and uncovered the potential of sepia ink as cancer therapeutics [10] . Sepia ink oligopeptide (SIO) is a tripeptide isolated from sepia esculenta by enzymolysis. The peptide in nature displays capacity in improving immune response, inhibiting tumor neo-angiogenesis and metastasis, eradicating tumor cells, inducing apoptosis and arresting cell cycle. Consistent with this notion, our previous data demonstrated that SIO significantly suppressed tumor cell proliferation and induced apoptosis in tumor cell culture. However, the molecular mechanism underlying its anti-tumor effect has not been fully elucidated.
Here we sought to investigate the molecular events in response to SIO treatment. In view of its intrinsic instability as peptide, we synthesized and structurally modified SIO (CSIO) with the basic chemical characteristics preserved. The apoptotic inducing effect of CSIO on lung cancer cells was first consolidated, and then our focus concentrated on the complex and fine-tuned apoptosis regulatory network, which roughly consists of three relative independent while inter-connected pathway: mitochondrial pathway, death receptor pathway and endoplasmic reticulum (ER) stress induced apoptosis [11] . We attempted to determine which pathway is critical for CSIO induced tumor cell apoptosis. The related and key factors in each pathway were carefully examined and specific inhibitors were employed to selectively block respective pathways. This study provided detailed scenario at molecular level during cell apoptosis elicited by SIO derivate treatment. The insightful depiction of the signaling cascade could contritube to strategy leading compound optimization and combination therapeutics.
Materials and Methods

Synthesis of CSIO peptide
The method to synthesize CSIO was described previously [12] . To improve the stability and bioavailability, here we adopted the peptide cyclization strategy with introduction two homocysteine 
Results
CSIO significantly induced apoptosis in A549 cell
Here we first set out to closely inspect the apoptotic pathway in response to SIO treatment, and attempted to uncover the underlying mechanism.We first determined the cell proliferation upon treatment with either mock or CSIO (5 µM) for up to 72 h using the commercial CCK-8 kit. The relative cell viability was remarkably compromised by CSIO co-incubation in a time-dependent manner (decreased up to 21±1.8% for 24 h, 32±0.9% for 48 h and 34±1% for 72 h, p<0.01) (Fig. 1A) . We next attempted to discriminate whether the effect on cell growth was caused by apoptosis induction. The general cell death was analyzed by Annexin V/PI double-staining immediately after CSIO treatment. The representative stainingpositive cells were shown in upper pane of Fig.  1B . Our results clearly demonstrated that low concentration of CSIO was enough to provoke dramatic apoptosis (increased up to 80±2.3% for 24 h, 135±4.3% for 48 h and 217±5.6% for 72 h, p<0.01) (Fig. 1B) . It's highly likely that the anti-tumor activity of CSIO could attribute to apoptosis-inducing effect.
CSIO
induced mitochondria-mediated apoptosis in A549 Next, we sought to interrogate the classical apoptotic pathways including mitochondrial pathway, ER stress induced apoptosis and death receptor pathway in lung cancer cells in response to CSIO treatment. In consistent with cytochrome C-mediated apoptotic signaling, our results demonstrated that CSIO treatment induced remarkable elevation of pro-apoptotic BAX, caspase-9 and cytoplasmic cytochrome C (Cyto-C) and decreased anti-apoptotic Bcl-2 at both transcript and protein levels (50±2% reduction of Bcl-2 mRNA, 148±7.6% increase of BAX, 153±8.1% of Caspase-9, 138±7.6% of Cyto-C mRNA, p<0.01) (53±3.4% reduction of Bcl-2 protein, 180±10.3% increase of BAX, 36±4% of Caspase-9, 47±4.5% of cytoplasmic Cyto-C protein, p<0.01) ( Fig. 2A, B) . To further validate the crucial role of mitochondrial apoptosis in CSIOelicited cell death, here we employed mdivi-1, a selective inhibitor of mitochondrial fission protein, to specifically block mitochondria mediated cell apoptosis [13] without influencing other apoptotic cues. We preliminarily evaluated the potential impact on mitochondrial dynamics via interrogation of relevant gene expressions. As shown in Fig. 3A , midiv-1 specifically inhibited Drp-1 expression whereas barely The data also demonstrated a significant activation of mitochondria-dependent pathway by CSIO. affected Fis1, Mfn and OPA1. In this setting, all molecular events including alterations in Bcl-2, Bax, caspase-9 and cyto-C expressions were reversed upon co-treatment with mdivi-1 Cell (Fig. 3B, C) . We have further ruled out the potential cytotoxicity of mdivi-1 (50 μM) in our system. Although slight inhibitory effect on cell proliferation was observed with high concentration of midiv-1 (~30% reduction in cell viability with 100 μM midiv-1), the dosage we adopted in this study showed none effects on both cell growth and apoptosis (Fig. 3D) . Therefore, our data indicated an important role of cyto-C mediated cell apoptosis in CSIO cytotoxicity against lung cancer cells.
CSIO induced death receptor pathway-mediated apoptosis in A549
Despite the above mentioned critical role of mitochondria pathway in CSIO induced apoptosis, we could not simply exclude the potential contribution of other cellular apoptotic signaling to CSIO-induced cell death. Next, we focused on the death receptor pathway and interrogated the key signaling nodes including Fas, Caspase-8 and NIK upon CSIO treatment. As shown in Fig. 4A and B, CSIO challenge markedly increased expressions of Fas, caspase-8 and NIK along the death receptor pathway (234±18.4% increase of Ras mRNA, 402±26.3% of Caspase-8, 205±18.6% of NIK respectively, p<0.01); (197±19.2% increase of Fas protein, 396±40.1% of Caspase-8, 162±13.4% of NIK respectively, p<0.01). The involvement of death receptor mediated apoptosis in response to CSIO treatment was further consolidated with unique inhibitor PDTC [14] . Administration with PDTC significantly reversed the expression alterations in Fas, caspase-8 and NIK (87±5% reduction of Fas mRNA, 54±2.1% of Caspase-8, 68±4.3% of NIK in comparison with mock treatment, p<0.01) (81±4.6% reduction of Fas protein, 73±6.2% of Caspase-8, 48±5% of NIK in comparison with mock treatment, p<0.01) (Fig. 5A and B) . Only slight inhibitory effect was observed with extremely high concentration of PDTC (Fig. 5C ). Likewise, our data supported an indispensable role of death receptor pathway in mediating CSIO-induced cell apoptosis in addition to mitochondrial signaling.
CSIO also stimulated ER pathway-mediated apoptosis in A549
In addition to mitochondrial pathway and death receptor pathway, we further characterized the ER stress pathway which was increasingly recognized to play critical role in stimulation of cell apoptosis [15] and might be involved in the CSIO-induced cell death in lung cancer cell lines. To this purpose, the critical effectors in this direction, including CHOP, Calpain and Caspase-12, were determined at both transcriptional and translational levels. The provoked ER stress was unambiguously demonstrated by the significant increase in CHOP mRNA and protein in response to CSIO treatment as shown in Fig. 6A and B (76±4.5% increase of CHOP mRNA, p<0.01) (278±18.4% increase of CHOP protein, p<0.01). However, no obvious inductions in Calpain and Caspase-12 were observed in CSIO-treated A549, which indicated an independence of CSIO-stimulated cell death on this sub-pathway. Similarly, the Calpain-specific inhibitor, ALLN [16] , significantly abrogated the CHOP induction imposed by CSIO-treatment (78.4±6.4% increase of CHOP mRNA, p<0.01; 71.3±2.4% increase of CHOP protein, p<0.01; Fig. 7A and B) . Similarly, only slight inhibitory effect was observed with extremely high concentration of ALLN (Fig. 7C) . Our results indicated CSIO-induced cell apoptosis partially mediated by ER stress pathway, which predominantly attributed to CHOP activation.
Discussion
Lung cancer is the most common malignance in human with high mortality and morbidity [17] . The etiology of this disease has been well characterized in comparison with other tumors, which predominately attribute to tobacco smoking, occupational exposure, environmental pollution and genetic or epigenetic mutations [18] . The overall survival heavily depends on early screening, diagnosis and interventions. A pilot study suggested that low-dose CT scan accounted for approximate 20% reduction in mortality [19] . Surgical 
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Cellular Physiology and Biochemistry resection is the most efficient option for early diagnosed patients and associated with relatively optimistic prognosis. Chemotherapy and radiotherapy are the first-line treatments for patients who are not amenable to surgery with local advance malignance [2] . Target drugs are applicable for patients with well-defined genetic mutations such as EGFR, KRAS and ALK [7] . However, most patients develop resistance and rapid relapse, which largely compromises its therapeutic effect. Immunotherapy is the emerging regime for clinical management of both hematologic and solid tumors, which harnesses patient's own immune system to eradicate tumor cells. The preliminary clinical trial with immune checkpoint inhibitors against PD-1/PD-L1 axis showed great benefit in increasing the overall survival, in comparison with docetaxel in non-small cell lung cancer patients, which led to immediate approval of nivolumab and pembrolizumab by FDA [20] . The randomized trial also suggested that only a small portion of lung cancer patients could benefit from this therapeutics, which necessitates intense search for sensitive and reliable biomarkers. Despite of a variety of clinical options available, the novel therapeutics are still under intensive exploitation. Sepia ink is a natural product and historically used for hemostasis in TCM [21] . Its medicinal value has been increasingly exploited in a variety of human diseases. For instance, therapeutic effect of low molecular weight chitosan containing sepia ink has been demonstrated in ethanol-induced gastric ulcer in rats [22] . Zhang et al. showed the beneficial effect of chitin and sepia ink hybrid sponge on the healing of burning wound in rat model via promoting the phagocytosis ability of macrophages [23] . Moreover, sepia ink extract provided a curative effect and anti-oxidative capacity on bile duct ligation, and could ameliorate the complications of live cholestasis [24] . Intriguingly, in combination with anti-fungal agent, sepia ink extract displayed therapeutic effect against invasive pulmonary aspergillosis [25] . The anti-tumor activity of sepia ink has been demonstrated in vitro by several investigations as well [26] [27] [28] . However, the most therapeutic potentials of sepia ink have been interrogated with crude extract, since the precise composition of sepia ink had not been fully characterized until now. Some effective compositions identified in sepia ink extract include polysaccharide, peptide and small molecule chemicals. Our previous study has demonstrated a tripeptide isolated from sepia ink induced apoptosis in prostate cancer cells in vitro for the first time [10] . However, the detailed molecular mechanism underlying the apoptosis elicited by SIO treatment has not been fully elucidated. Here we employed CSIO with cyclization chemical modification instead of SIO in consideration of improved stability and enhanced cell permeability, as measured with fluorescent probe-labelling technology [12] . Our results evaluated the anti-tumor property of this derived oligopeptide in vitro and demonstrated significant apoptosis induced by CSIO in lung cancer cell A549, which suggested a potential therapeutic effect of CSIO in this disease.
In this study, we concentrated on understanding the molecular mechanism underlying CSIO-induced cell apoptosis in lung cancer. We systematically investigated an array of molecular events during the apoptotic process, which is well-coordinated and mediated mainly by three well-recognized pathways [29] . In addition to its cellular energy factory role, mitochondria also served as central hub in regulating cell apoptosis [30] . The release of cyto-C from mitochondria into the cytosol leads to irreversible apoptotic signaling cascade [31] . The mitochondrial membrane permeability is under strict control of Bcl-2 family and counter-acted by Bax [32] . Our previous study preliminarily demonstrated that the strong cell penetration of stable CSIO in A549 and H1299 inhibited cell proliferation and induced cell apoptosis via down-regulating anti-apoptotic Bcl-2 and up-regulating pro-apoptotic P53 and caspase-3 [12] . In line with this observation, here we consolidated the suppression of Bcl-2 in response to CSIO in A549. Furthermore, we have characterized increased Bax, Caspase-12 and cytoplasmic cyto-C upon CSIO treatment. Our results unambiguously demonstrated that CSIO stimulated apoptosis via the mitochondria pathway. Simultaneously, we employed mdivi-1, a cell-permeable selective inhibitor of mitochondrial division DRP (dynamin-related GTPase) and inhibitor of the mitochondrial division dynamin (Dnm1), to specifically block the mitochondrial pathway [33] . In this setting, mitochondrial pathway activation has been completely abolished.
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Next, we sought to clarify whether other pathways were involved in CSIO-stimulated cell death in A549 as well. In addition to mitochondria pathway, death receptor pathway also played a critical role in apoptotic signaling [34] . We have examined an array of key factors along this cascade in response to CSIO challenge. Our data clearly demonstrated that CSIO treatment significantly up-regulated Fas, caspase-8 and NIK at both transcript and protein levels, which indicated an indispensable role of death receptor pathway in mediating CSIO induced apoptosis in A549. Caspase cascade eventually activates NIK and leads to NF-κB dissociation and release [35] . The nucleus translocated NF-κB subsequently stimulates expression of downstream genes in promotion apoptotic process. Likewise, we employed the NF-κB specific inhibitor PDTC, which readily abrogated death receptor pathway activation by CSIO treatment [14] . Therefore, our results added another dimension to the apoptotic effect of CSIO in lung cancer. Noteworthily, the detailed mechanism underlying CSIO-activated death receptor pathway is still elusive at present and requires further elucidations. In view of the critical role of Smac in relieving the inhibitory effect of the inhibitor of apoptosis protein (IAP) and eliciting death receptor pathway-mediated cell death [36] , we hypothesized here that CSIO might function in a similar way to directly interact with IAP, which required experimental validation in future studies.
At last, we evaluated the role of ER stress in CSIO-induced cell apoptosis [15, 37] . Overloaded or malfunctioned ER stimulates release of Ca 2+ into the cytosol, which in turn activates Calpain. The active Calpain translocates to ER membrane and promotes cleavage of caspase-12. Simultaneously, CHOP expression is up-regulated in response to ER stress. CHOP stimulates Bax transportation to the mitochondria and suppresses Bcl-2 expression, which contributes to mitochondrial pathway mediated apoptosis [38] . In addition, CHOP activation decreases intracellular glutathione content, disturbs redox homeostasis and induces apoptosis [39] . We have observed dramatic increase of CHOP upon CSIO treatment and slight changes in both caspase-12 and Calpain. Application of Calpain inhibitor ALLN [16] significantly suppressed CHOP up-regulation and related cell apoptosis. Our data also supported an important role of ER stress in mediating CSIO-elicited apoptosis. Although our observations indicated that activation of all three pathways converging on cell death in response to CSIO, more firm conclusion remains to be reached via either systematic interrogation by microarray or thorough experimental validations.
Conclusion
In summary, we have extensively characterized cell apoptotic events in response to CSIO treatment. Our results demonstrate all the three classical pathways potentially contribute to CSIO elicited apoptotic effect. Our in vitro study also warrants anti-tumor investigation in tumor animal model in vivo.
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